Assignee profile
Shanghai Hengrui Pharmaceutical
Coverage of patents, compounds and activity records linked to this assignee.
5 patents22 compounds64 activity records
Summary
AssigneeShanghai Hengrui Pharmaceutical
Filing years2021-2025
Patents5
Compounds22
Activity records64
Patent families5
Targets2
Assay familiesdegradation, viability
Activity metricsDC50, Dmax, IC50, cell_viability, degradation
Overview
Target distribution and active-compound trend
Target distribution
64 activity records
Active compounds by publication year
Distinct compounds linked to assignee patent publications
Activity compounds and values